gemtuzumab ozogamicin
Sign in to saveAlso known as CMA-676, CDP-771, CMC-676, WAY-CMA-676
pharmaceutical drug
In the Vinony graph
Vinony's link graph records 357 inbound references to gemtuzumab ozogamicin, and connects out to acute myeloid leukemia, fusion protein and antibody-drug conjugate.
It sits within the topics Antibody-drug conjugates, Chemicals that do not have a ChemSpider ID assigned and Drugboxes which contain changes to verified fields.
Vinony links it to 17 Wikipedia language editions.
Chemical data
Drug data · ChEMBL
Withdrawn- Max clinical phase
- Approved
- Molecule type
- Antibody drug conjugate
- First approval
- 2000
- Admin. routes
- parenteral
- Indications
- acute myeloid leukemia, leukemia, neoplasm, chronic lymphocytic leukemia
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 151500
- Has use
- medication
Show 4 more facts
- medical condition treated
- acute myeloid leukemia
- World Health Organisation international non-proprietary name
- gemtuzumab ozogamicin
- subject has role
- antibody-drug conjugate
- legal status (medicine)
- boxed warning
Sources (7)
via Wikidata · CC0
Connections
acute myeloid leukemia
Entity
fusion protein
Entity
antibody-drug conjugate
Entity
humanized antibody
Entity
dinutuximab
Entity
diarrhea
Entity
The New York Times
Entity
public domain
Entity
digital object identifier
Entity
leukemia
Entity
stem cell
Entity
bleeding
Entity
lymphatic system
Entity
Pfizer
Entity
molar mass
Entity
nausea
Entity
PubMed
Entity
antigen
Entity
lymphoma
Entity
hypoxia
Disease
Categories
Antibody-drug conjugatesChemicals that do not have a ChemSpider ID assignedDrugboxes which contain changes to verified fieldsDrugboxes which contain changes to watched fieldsDrugs developed by PfizerDrugs developed by WyethDrugs that are a monoclonal antibodyDrugs with non-standard legal statusHepatotoxinsMonoclonal antibodies for tumorsOrphan drugsSource attributionWithdrawn drugs